Brent Furse
Vorstandsvorsitzender bei Vero Biotech LLC
Profil
Brent Furse currently works at Vero Biotech LLC, as President, Chief Executive Officer & Director from 2016 and Vero Biotech, Inc., as President, Chief Executive Officer & Director from 2016.
Mr. Furse also formerly worked at Anthera Pharmaceuticals, Inc., as Independent Director, The Medicines Co., as Chief Customer Officer & Senior Vice President from 2012 to 2014, and Cardiorentis AG, as President & Chief Commercial Officer.
Mr. Furse received his undergraduate degree and Masters Business Admin degree from Mercer University and undergraduate degree from Kennesaw State University.
Aktive Positionen von Brent Furse
| Unternehmen | Position | Beginn |
|---|---|---|
Vero Biotech LLC
 Vero Biotech LLC Pharmaceuticals: MajorHealth Technology Vero Biotech LLC is a biotechnology company, which focuses on the design, development and commercialization of inhaled nitric oxide delivery systems to address the unmet medical needs of patients with cardiopulmonary conditions. It develops a drug, GeNOsyl to meet the needs of patients and care providers. The company was founded by David H. Fine in 2006 and is headquartered in Atlanta, GA. | Vorstandsvorsitzender | 01.06.2016 |
| Vero Biotech, Inc. | Vorstandsvorsitzender | 01.06.2016 |
Ehemalige bekannte Positionen von Brent Furse
| Unternehmen | Position | Ende |
|---|---|---|
| THE MEDICINES COMPANY | Corporate Officer/Principal | 01.01.2014 |
| ANTHERA PHARMACEUTICALS, INC. | Direktor/Vorstandsmitglied | - |
Cardiorentis AG
 Cardiorentis AG Pharmaceuticals: MajorHealth Technology Cardiorentis AG operates as a biopharmaceutical company. It offers novel therapies to the treatment of heart failure and related cardiovascular diseases. The company was founded in 2010 and is headquartered in Zug, Switzerland. | Präsident | - |
Ausbildung von Brent Furse
| Mercer University | Masters Business Admin |
| Kennesaw State University | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| ANTHERA PHARMACEUTICALS, INC. | Health Technology |
| Private Unternehmen | 4 |
|---|---|
The Medicines Co.
 The Medicines Co. Pharmaceuticals: MajorHealth Technology The Medicines Co. is a biopharmaceutical company, which focuses on saving lives, alleviating suffering and contributing to the economics of healthcare by focusing on acute and intensive care hospitals worldwide. The firm markets its brands Angiomax, Cleviprex, injectable emulsion, Ionsys, Kengreal, Minocin for injection, and Orbactiv. The company was founded by Clive A. Meanwell, Helmut Giersiefen, John W. Villiger and T. Scott Johnson on July 31, 1996 and is headquartered in Parsippany, NJ. | Health Technology |
Vero Biotech LLC
Vero Biotech LLC Pharmaceuticals: MajorHealth Technology Vero Biotech LLC is a biotechnology company, which focuses on the design, development and commercialization of inhaled nitric oxide delivery systems to address the unmet medical needs of patients with cardiopulmonary conditions. It develops a drug, GeNOsyl to meet the needs of patients and care providers. The company was founded by David H. Fine in 2006 and is headquartered in Atlanta, GA. | Health Technology |
Cardiorentis AG
Cardiorentis AG Pharmaceuticals: MajorHealth Technology Cardiorentis AG operates as a biopharmaceutical company. It offers novel therapies to the treatment of heart failure and related cardiovascular diseases. The company was founded in 2010 and is headquartered in Zug, Switzerland. | Health Technology |
| Vero Biotech, Inc. |
